Treatment of tumour recurrence after resection of hepatocellular carcinoma. Analysis of 97 consecutive patients

European Journal of Surgical Oncology

Volumn 33, Issue 6, 2007, Pages 746-751

  Tralhao J G ^a   Dagher, I ^a   Lino, T ^b   Roudie J ^a   Franco, D ^a  

^a HÔPITAL ANTOINE BÉCLÈRE   (France)

^b INESC COIMBRA   (Portugal)

Author keywords

Hepatocellular carcinoma; Recurrence; Treatment

Indexed keywords

ALCOHOL;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER SURVIVAL; CHEMOEMBOLIZATION; CONSERVATIVE TREATMENT; CONTROLLED STUDY; DEATH; FEMALE; HEMIHEPATECTOMY; HUMAN; LIVER CELL CARCINOMA; LIVER FUNCTION; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PATIENT SAFETY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; REOPERATION; SPINE METASTASIS; SPINE SURGERY; STATISTICAL SIGNIFICANCE; SURGICAL MORTALITY; SURGICAL TECHNIQUE; SURVIVAL RATE; TUMOR RECURRENCE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; DISEASE-FREE SURVIVAL; ETHANOL; FEMALE; HEPATECTOMY; HUMANS; INJECTIONS, INTRALESIONAL; LIVER NEOPLASMS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; REOPERATION; SPINAL NEOPLASMS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 34447101011     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2006.11.015     Document Type: Article

References (32)

1. Franco D., Capussotti L., Smadja C., et al. Resection of hepatocellular carcinomas. Results in 72 European patients with cirrhosis. Gastroenterology 98 (1990) 733-738
2. Belghiti J., Panis Y., Farges O., Benhamou J.P., and Fekete F. Intrahepatic recurrence after resection of hepatocellular carcinoma complicating cirrhosis. Ann Surg 214 (1991) 114-117
3. Chen M.F., Hwang T.L., Jeng L.B., Wang C.S., Jan Y.Y., and Chen S.C. Postoperative recurrence of hepatocellular carcinoma. Two hundred five consecutive patients who underwent hepatic resection in 15 years. Arch Surg 129 (1994) 738-742
4. Poon R.T., Fan S.T., Lo C.M., Liu C.L., and Wong J. Intrahepatic recurrence after curative resection of hepatocellular carcinoma: long-term results of treatment and prognostic factors. Ann Surg 229 (1999) 216-222
5. Poon R.T., Fan S.T., Ng I.O., Lo C.M., Liu C.L., and Wong J. Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma. Cancer 89 (2000) 500-507
6. Cha C., Fong Y., Jarnagin W.R., Blumgart L.H., and DeMatteo R.P. Predictors and patterns of recurrence after resection of hepatocellular carcinoma. J Am Coll Surg 197 (2003) 753-758
7. Chen W.T., Chau G.Y., Lui W.Y., et al. Recurrent hepatocellular carcinoma after hepatic resection: prognostic factors and long-term outcome. Eur J Surg Oncol 30 (2004) 414-420
8. Poon R.T., Fan S.T., O'Suilleabhain C.B., and Wong J. Aggressive management of patients with extrahepatic and intrahepatic recurrences of hepatocellular carcinoma by combined resection and locoregional therapy. J Am Coll Surg 195 (2002) 311-318
9. Marin-Hargreaves G., Azoulay D., and Bismuth H. Hepatocellular carcinoma: surgical indications and results. Crit Rev Oncol Hematol 47 (2003) 13-27
10. Nakajima Y., Ko S., Kanamura T., et al. Repeat liver resection for hepatocellular carcinoma. J Am Coll Surg 192 (2001) 339-344
11. O'Suilleabhain C.B., Poon R.T., Lau C.W., and Fan S.T. Repeated resections of extrahepatic metastases after hepatic resection: an aggressive approach to hepatocellular carcinoma. Hepatogastroenterology 51 (2004) 825-829
12. Nakajima J., Tanaka M., Matsumoto J., Takeuchi E., Fukami T., and Takamoto S. Appraisal of surgical treatment for pulmonary metastasis from hepatocellular carcinoma. World J Surg 29 (2005) 715-718
13. Pugh R.N.H., Murray-Lyon I.M., Dawson J.L., et al. Transection of the esophagus for esophageal varices. Br J Surg (1973) 646-649
14. Lam C.M., Lo C.M., Yuen W.K., Liu C.L., and Fan S.T. Prolonged survival in selected patients following surgical resection for pulmonary metastasis from hepatocellular carcinoma. Br J Surg 85 (1998) 1198-1200
15. Sun H.C., Tang Z.Y., Ma Z.C., et al. The prognostic factor for outcome following second resection for intrahepatic recurrence of hepatocellular carcinoma with a hepatitis B virus infection background. J Cancer Res Clin Oncol 131 (2005) 284-288
16. Cha C.H., Ruo L., Fong Y., et al. Resection of hepatocellular carcinoma in patients otherwise eligible for transplantation. Ann Surg 238 (2003) 315-321 (discussion 321-3)
17. Adam R., Azoulay D., Castaing D., et al. Liver resection as a bridge to transplantation for hepatocellular carcinoma on cirrhosis: a reasonable strategy?. Ann Surg 238 (2003) 508-518 (discussion 518-9)
18. Schwartz J.D., Schwartz M., Mandeli J., and Sung M. Neoadjuvant and adjuvant therapy for resectable hepatocellular carcinoma: review of the randomised clinical trials. Lancet Oncol 3 (2002) 593-603
19. Lau W.Y., Leung T.W., Ho S.K., et al. Adjuvant intra-arterial iodine-131-labelled lipiodol for resectable hepatocellular carcinoma: a prospective randomised trial. Lancet 353 (1999) 797-801
20. Raoul J.L., Messner M., Boucher E., Bretagne J.F., Campion J.P., and Boudjema K. Preoperative treatment of hepatocellular carcinoma with intra-arterial injection of 131I-labelled lipiodol. Br J Surg 90 (2003) 1379-1383
21. Tabone M., Vigano L., Laudi C., Ferrero A., Pellerito R., and Capussotti L. Adjuvant iodine-131-labeled lipiodol for prevention of intrahepatic recurrence of hepatocellular carcinoma: which is the best treatment schedule?. Hepatology 41 (2005) 1433 (author reply 1433-4)
22. Kubo S., Nishiguchi S., Hirohashi K., et al. Effects of long-term postoperative interferon-alpha therapy on intrahepatic recurrence after resection of hepatitis C virus-related hepatocellular carcinoma. A randomized, controlled trial. Ann Intern Med 134 10 (2001) 963-967
23. Nishiguchi S., Tamori A., and Kubo S. Effect of long-term postoperative interferon therapy on intrahepatic recurrence and survival rate after resection of hepatitis C virus-related hepatocellular carcinoma. Intervirology 48 (2005) 71-75
24. Butterfield L.H. Immunotherapeutic strategies for hepatocellular carcinoma. Gastroenterology 127 5 Suppl. 1 (2004) S232-S241
25. Takayama T., Sekine T., Makuuchi M., et al. Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial. Lancet 356 (2000) 802-807
26. Lygidakis N.J., and Tsiliakos S. Multidisciplinary management of hepatocellular carcinoma. Hepatogastroenterology 43 (1996) 1611-1619
27. Kawata A., Une Y., Hosokawa M., et al. Adjuvant chemoimmunotherapy for hepatocellular carcinoma patients. Adriamycin, interleukin-2, and lymphokine-activated killer cells versus adriamycin alone. Am J Clin Oncol 18 (1995) 257-262
28. Poon R.T., Fan S.T., Lo C.M., Liu C.L., and Wong J. Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function: implications for a strategy of salvage transplantation. Ann Surg 235 (2002) 373-382
29. Belghiti J., Cortes A., Abdalla E.K., et al. Resection prior to liver transplantation for hepatocellular carcinoma. Ann Surg 238 (2003) 885-892 (discussion 892-3)
30. Shuto T., Hirohashi K., Kubo S., et al. Treatment of adrenal metastases after hepatic resection of a hepatocellular carcinoma. Dig Surg 18 (2001) 294-297
31. Yeh C.N., Chen M.F., and Jeng L.B. Resection of peritoneal implantation from hepatocellular carcinoma. Ann Surg Oncol 9 (2002) 863-868
32. Lo C.M., Lai E.C., Fan S.T., Choi T.K., and Wong J. Resection for extrahepatic recurrence of hepatocellular carcinoma. Br J Surg 81 (1994) 1019-1021